These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31267008)

  • 41. Gene therapy for mucopolysaccharidosis.
    Bosch A; Heard JM
    Int Rev Neurobiol; 2003; 55():271-96. PubMed ID: 12968541
    [No Abstract]   [Full Text] [Related]  

  • 42. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
    Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
    J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic mucopolysaccharidoses, mannosidosis, sialidosis, galactosialidosis, and I-cell disease. Ultrastructural analysis of cultured fibroblasts.
    Takahashi K; Naito M; Suzuki Y
    Acta Pathol Jpn; 1987 Mar; 37(3):385-400. PubMed ID: 3113172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease.
    Squeri G; Passerini L; Ferro F; Laudisa C; Tomasoni D; Deodato F; Donati MA; Gasperini S; Aiuti A; Bernardo ME; Gentner B; Naldini L; Annoni A; Biffi A; Gregori S
    Mol Ther; 2019 Jul; 27(7):1215-1227. PubMed ID: 31060789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene-Based Approaches to Inherited Neurometabolic Diseases.
    Poletti V; Biffi A
    Hum Gene Ther; 2019 Oct; 30(10):1222-1235. PubMed ID: 31397176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent trends in mucopolysaccharidosis research.
    Kobayashi H
    J Hum Genet; 2019 Feb; 64(2):127-137. PubMed ID: 30451936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age.
    Megens JH; de Wit M; van Hasselt PM; Boelens JJ; van der Werff DB; de Graaff JC
    Paediatr Anaesth; 2014 May; 24(5):521-7. PubMed ID: 24612129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene therapy. Viral vectors still pack surprises.
    Marshall E
    Science; 2001 Nov; 294(5547):1640. PubMed ID: 11721031
    [No Abstract]   [Full Text] [Related]  

  • 49. Versatility of gene therapy vectors through viruses.
    Barzon L; Stefani AL; Pacenti M; Palù G
    Expert Opin Biol Ther; 2005 May; 5(5):639-62. PubMed ID: 15934840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial.
    Schweighardt B; Tompkins T; Lau K; Jesaitis L; Qi Y; Musson DG; Farmer P; Haller C; Shaywitz AJ; Yang K; O'Neill CA
    Clin Ther; 2015 May; 37(5):1012-1021.e6. PubMed ID: 25487082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a novel missense mutation in Brazilian patient with a severe form of mucopolysaccharidosis type IVA.
    Kubaski F; Brusius-Facchin AC; Palhares HM; Balarin MA; Viapiana-Camelier M; Guidobono R; Burin MG; Giugliani R; Leistner-Segal S
    Gene; 2013 Mar; 517(1):112-5. PubMed ID: 23313879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucopolysaccharidosis.
    Danos O; Heard JM
    Mol Cell Biol Hum Dis Ser; 1995; 5():350-67. PubMed ID: 9532574
    [No Abstract]   [Full Text] [Related]  

  • 53. Mucopolysaccharidoses type IV A (Morquio syndrome): a case series of three siblings.
    Rekka P; Rathna PV; Jagadeesh S; Seshadri S
    J Indian Soc Pedod Prev Dent; 2012; 30(1):66-9. PubMed ID: 22565520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucopolysaccharidoses seen in adults in rheumatology.
    Mitrovic S; Gouze H; Gossec L; Schaeverbeke T; Fautrel B
    Joint Bone Spine; 2017 Dec; 84(6):663-670. PubMed ID: 28196778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene therapy for lysosomal storage disorders.
    Barranger JM; Novelli EA
    Expert Opin Biol Ther; 2001 Sep; 1(5):857-67. PubMed ID: 11728220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy.
    Gray-Edwards HL; Brunson BL; Holland M; Hespel AM; Bradbury AM; McCurdy VJ; Beadlescomb PM; Randle AN; Salibi N; Denney TS; Beyers RJ; Johnson AK; Voyles ML; Montgomery RD; Wilson DU; Hudson JA; Cox NR; Baker HJ; Sena-Esteves M; Martin DR
    Mol Genet Metab; 2015; 116(1-2):80-7. PubMed ID: 25971245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mucopolysaccharidosis].
    Gajdos A
    Nouv Presse Med; 1977 May; 6(20):1745-6. PubMed ID: 141039
    [No Abstract]   [Full Text] [Related]  

  • 58. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
    Anson DS; Bielicki J; Hopwood JJ
    Hum Gene Ther; 1992 Aug; 3(4):371-9. PubMed ID: 1525210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Research Progress of nucleic acid delivery vectors for gene therapy.
    Jiao Y; Xia ZL; Ze LJ; Jing H; Xin B; Fu S
    Biomed Microdevices; 2020 Jan; 22(1):16. PubMed ID: 31989315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.